SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-046727
Filing Date
2024-05-24
Accepted
2024-05-24 17:10:10
Documents
14
Period of Report
2024-05-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea020673001-8k_avalon.htm   iXBRL 8-K 28789
2 PRESS RELEASE, DATED MAY 24, 2024 ea020673001ex99-1_avalon.htm EX-99.1 8801
  Complete submission text file 0001213900-24-046727.txt   216124

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE albt-20240522.xsd EX-101.SCH 3039
4 XBRL LABEL FILE albt-20240522_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE albt-20240522_pre.xml EX-101.PRE 22375
17 EXTRACTED XBRL INSTANCE DOCUMENT ea020673001-8k_avalon_htm.xml XML 3686
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

IRS No.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38728 | Film No.: 24985457
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)